Rank | Gene Set | Z-score |
---|---|---|
1 | angiotensin maturation (GO:0002003) | 5.51076725 |
2 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.24425495 |
3 | epoxygenase P450 pathway (GO:0019373) | 5.15938924 |
4 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.52916503 |
5 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 4.30859771 |
6 | intestinal absorption (GO:0050892) | 4.22713020 |
7 | cellular glucuronidation (GO:0052695) | 4.11458647 |
8 | uronic acid metabolic process (GO:0006063) | 4.07036465 |
9 | glucuronate metabolic process (GO:0019585) | 4.07036465 |
10 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.85696006 |
11 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.85696006 |
12 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.81831050 |
13 | urate metabolic process (GO:0046415) | 3.81450842 |
14 | exogenous drug catabolic process (GO:0042738) | 3.75063488 |
15 | phospholipid efflux (GO:0033700) | 3.74129729 |
16 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.69315130 |
17 | hormone catabolic process (GO:0042447) | 3.66410405 |
18 | regulation of cholesterol esterification (GO:0010872) | 3.60554438 |
19 | valine metabolic process (GO:0006573) | 3.60227645 |
20 | bile acid and bile salt transport (GO:0015721) | 3.59793747 |
21 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.57273893 |
22 | drug metabolic process (GO:0017144) | 3.56720728 |
23 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.49433232 |
24 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.47382749 |
25 | neutrophil activation involved in immune response (GO:0002283) | 3.45514210 |
26 | cholesterol efflux (GO:0033344) | 3.43890826 |
27 | adhesion of symbiont to host cell (GO:0044650) | 3.36670739 |
28 | virion attachment to host cell (GO:0019062) | 3.36670739 |
29 | modulation by symbiont of host immune response (GO:0052553) | 3.35314524 |
30 | positive regulation by symbiont of host defense response (GO:0052509) | 3.35314524 |
31 | modulation by symbiont of host defense response (GO:0052031) | 3.35314524 |
32 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.35314524 |
33 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.35314524 |
34 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.35314524 |
35 | lipoprotein transport (GO:0042953) | 3.34658010 |
36 | heme transport (GO:0015886) | 3.33464834 |
37 | drug transmembrane transport (GO:0006855) | 3.32476008 |
38 | regulation of fibrinolysis (GO:0051917) | 3.32025961 |
39 | bile acid metabolic process (GO:0008206) | 3.31244596 |
40 | urea metabolic process (GO:0019627) | 3.30699345 |
41 | glycosphingolipid catabolic process (GO:0046479) | 3.29190104 |
42 | plasma lipoprotein particle assembly (GO:0034377) | 3.29138956 |
43 | drug transport (GO:0015893) | 3.27889758 |
44 | peptide hormone processing (GO:0016486) | 3.26104698 |
45 | omega-hydroxylase P450 pathway (GO:0097267) | 3.23521102 |
46 | glycolipid catabolic process (GO:0019377) | 3.22548621 |
47 | NADH metabolic process (GO:0006734) | 3.20938443 |
48 | vitamin biosynthetic process (GO:0009110) | 3.18821545 |
49 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.18644340 |
50 | regulation of triglyceride catabolic process (GO:0010896) | 3.18339355 |
51 | phenylpropanoid metabolic process (GO:0009698) | 3.17880387 |
52 | high-density lipoprotein particle remodeling (GO:0034375) | 3.16929594 |
53 | urea cycle (GO:0000050) | 3.13144141 |
54 | protein-lipid complex assembly (GO:0065005) | 3.12628208 |
55 | regulation of guanylate cyclase activity (GO:0031282) | 3.11793582 |
56 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.07435084 |
57 | transcytosis (GO:0045056) | 3.07394292 |
58 | toxin transport (GO:1901998) | 3.06781716 |
59 | cysteine metabolic process (GO:0006534) | 3.06099710 |
60 | protein-lipid complex remodeling (GO:0034368) | 3.05300914 |
61 | macromolecular complex remodeling (GO:0034367) | 3.05300914 |
62 | plasma lipoprotein particle remodeling (GO:0034369) | 3.05300914 |
63 | regulation of bile acid biosynthetic process (GO:0070857) | 3.04329892 |
64 | reverse cholesterol transport (GO:0043691) | 3.03598188 |
65 | regulation of cholesterol homeostasis (GO:2000188) | 3.02278328 |
66 | macroautophagy (GO:0016236) | 3.01467362 |
67 | nitrogen cycle metabolic process (GO:0071941) | 2.99478216 |
68 | flavonoid metabolic process (GO:0009812) | 2.99033507 |
69 | lysine metabolic process (GO:0006553) | 2.98088209 |
70 | lysine catabolic process (GO:0006554) | 2.98088209 |
71 | lipoprotein metabolic process (GO:0042157) | 2.94173380 |
72 | L-phenylalanine metabolic process (GO:0006558) | 2.92324561 |
73 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.92324561 |
74 | adhesion of symbiont to host (GO:0044406) | 2.92320495 |
75 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.89482226 |
76 | L-phenylalanine catabolic process (GO:0006559) | 2.89482226 |
77 | respiratory burst (GO:0045730) | 2.88832751 |
78 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.87300699 |
79 | regulation of protein activation cascade (GO:2000257) | 2.86789125 |
80 | alkaloid metabolic process (GO:0009820) | 2.85701980 |
81 | ceramide catabolic process (GO:0046514) | 2.85219919 |
82 | positive regulation of interferon-alpha production (GO:0032727) | 2.83942134 |
83 | regulation of vitamin metabolic process (GO:0030656) | 2.82454276 |
84 | vitamin D metabolic process (GO:0042359) | 2.82154120 |
85 | glycoside metabolic process (GO:0016137) | 2.81732290 |
86 | peptide catabolic process (GO:0043171) | 2.79775510 |
87 | protein carboxylation (GO:0018214) | 2.79324226 |
88 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.79324226 |
89 | response to thyroid hormone (GO:0097066) | 2.79043158 |
90 | regulation of complement activation (GO:0030449) | 2.78979662 |
91 | intestinal cholesterol absorption (GO:0030299) | 2.77000155 |
92 | branched-chain amino acid metabolic process (GO:0009081) | 2.76996546 |
93 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.76974788 |
94 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.76974788 |
95 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 2.76813101 |
96 | endocrine process (GO:0050886) | 2.76813101 |
97 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 2.76813101 |
98 | tricarboxylic acid metabolic process (GO:0072350) | 2.76149301 |
99 | positive regulation of antigen processing and presentation (GO:0002579) | 2.75853267 |
100 | plasma lipoprotein particle organization (GO:0071827) | 2.75834724 |
101 | negative regulation of cholesterol transport (GO:0032375) | 2.75389749 |
102 | negative regulation of sterol transport (GO:0032372) | 2.75389749 |
103 | low-density lipoprotein particle remodeling (GO:0034374) | 2.74509880 |
104 | ethanol metabolic process (GO:0006067) | 2.73978614 |
105 | negative regulation of protein activation cascade (GO:2000258) | 2.73534391 |
106 | fibrinolysis (GO:0042730) | 2.72851328 |
107 | sulfur amino acid catabolic process (GO:0000098) | 2.72467144 |
108 | protein-lipid complex subunit organization (GO:0071825) | 2.70059421 |
109 | glyoxylate metabolic process (GO:0046487) | 2.69863422 |
110 | regulation of interferon-alpha production (GO:0032647) | 2.69646492 |
111 | positive regulation of lipid catabolic process (GO:0050996) | 2.67939711 |
112 | pinocytosis (GO:0006907) | 2.67766315 |
113 | regulation of extracellular matrix disassembly (GO:0010715) | 2.66760635 |
114 | immunoglobulin mediated immune response (GO:0016064) | 2.66698158 |
115 | bile acid biosynthetic process (GO:0006699) | 2.65175913 |
116 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.65144173 |
117 | amino-acid betaine metabolic process (GO:0006577) | 2.64250558 |
118 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.63513493 |
119 | arginine metabolic process (GO:0006525) | 2.63316723 |
120 | organic cation transport (GO:0015695) | 2.62700441 |
121 | triglyceride homeostasis (GO:0070328) | 2.62366398 |
122 | acylglycerol homeostasis (GO:0055090) | 2.62366398 |
123 | complement activation, alternative pathway (GO:0006957) | 2.62296023 |
124 | negative regulation of hemostasis (GO:1900047) | 2.61294567 |
125 | negative regulation of blood coagulation (GO:0030195) | 2.61294567 |
126 | negative regulation of complement activation (GO:0045916) | 2.60929611 |
127 | carnitine metabolic process (GO:0009437) | 2.60535020 |
128 | L-ascorbic acid metabolic process (GO:0019852) | 2.59153049 |
129 | fatty acid beta-oxidation (GO:0006635) | 2.58530603 |
130 | * sphingolipid catabolic process (GO:0030149) | 2.57695682 |
131 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.57139794 |
132 | * membrane lipid catabolic process (GO:0046466) | 2.56660145 |
133 | negative regulation of fibrinolysis (GO:0051918) | 2.56287111 |
134 | macrophage activation involved in immune response (GO:0002281) | 2.55862751 |
135 | maintenance of gastrointestinal epithelium (GO:0030277) | 2.55288283 |
136 | negative regulation of coagulation (GO:0050819) | 2.54390413 |
137 | lipid oxidation (GO:0034440) | 2.51541491 |
138 | leukotriene metabolic process (GO:0006691) | 2.51223878 |
139 | response to peptidoglycan (GO:0032494) | 2.50356092 |
140 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.50328193 |
141 | cellular extravasation (GO:0045123) | 2.50293731 |
142 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.49993512 |
143 | homocysteine metabolic process (GO:0050667) | 2.49244976 |
144 | fatty acid oxidation (GO:0019395) | 2.46983358 |
145 | branched-chain amino acid catabolic process (GO:0009083) | 2.46400057 |
146 | quaternary ammonium group transport (GO:0015697) | 2.43427753 |
147 | reactive oxygen species biosynthetic process (GO:1903409) | 2.42222973 |
148 | lipoxygenase pathway (GO:0019372) | 2.42031328 |
149 | regulation of cholesterol storage (GO:0010885) | 2.40813758 |
150 | apoptotic cell clearance (GO:0043277) | 2.39833406 |
151 | T cell migration (GO:0072678) | 2.38051072 |
152 | response to host immune response (GO:0052572) | 2.36376594 |
153 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.36376594 |
154 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.36166575 |
155 | superoxide anion generation (GO:0042554) | 2.35568576 |
156 | fatty acid catabolic process (GO:0009062) | 2.35474340 |
157 | alpha-linolenic acid metabolic process (GO:0036109) | 2.35140915 |
158 | modified amino acid transport (GO:0072337) | 2.34720148 |
159 | regulation of apoptotic cell clearance (GO:2000425) | 2.33832959 |
160 | cellular modified amino acid catabolic process (GO:0042219) | 2.33575202 |
161 | regulation of antigen processing and presentation (GO:0002577) | 2.31658622 |
162 | response to type I interferon (GO:0034340) | 2.31285561 |
163 | short-chain fatty acid metabolic process (GO:0046459) | 2.29746428 |
164 | leukotriene biosynthetic process (GO:0019370) | 2.28728289 |
165 | neutrophil activation (GO:0042119) | 2.27667456 |
166 | type I interferon signaling pathway (GO:0060337) | 2.27286144 |
167 | cellular response to type I interferon (GO:0071357) | 2.27286144 |
168 | detection of molecule of bacterial origin (GO:0032490) | 2.26810511 |
169 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.26258994 |
170 | positive regulation of macrophage differentiation (GO:0045651) | 2.24757321 |
171 | response to interferon-beta (GO:0035456) | 2.24652375 |
172 | leukocyte aggregation (GO:0070486) | 2.24508932 |
173 | drug catabolic process (GO:0042737) | 2.24345220 |
174 | renal absorption (GO:0070293) | 2.23403996 |
175 | granulocyte activation (GO:0036230) | 2.23352569 |
176 | fructose metabolic process (GO:0006000) | 2.20980665 |
177 | myeloid cell activation involved in immune response (GO:0002275) | 2.20499391 |
178 | response to interferon-alpha (GO:0035455) | 2.20031695 |
179 | detection of other organism (GO:0098543) | 2.19501755 |
180 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.19234799 |
181 | mitochondrial calcium ion transport (GO:0006851) | 2.18640644 |
182 | 2-oxoglutarate metabolic process (GO:0006103) | 2.18293275 |
183 | mannose metabolic process (GO:0006013) | 2.17582564 |
184 | oligosaccharide catabolic process (GO:0009313) | 2.17363813 |
185 | ethanol oxidation (GO:0006069) | 2.17344697 |
186 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.17175055 |
187 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.16776702 |
188 | response to host (GO:0075136) | 2.16776702 |
189 | response to host defenses (GO:0052200) | 2.16776702 |
190 | leukocyte cell-cell adhesion (GO:0007159) | 2.16621496 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.69307215 |
2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.20365276 |
3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.91970183 |
4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.51924458 |
5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.44808361 |
6 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.20520025 |
7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.13968025 |
8 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.92608873 |
9 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.91619356 |
10 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.88554773 |
11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.72739190 |
12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.67535382 |
13 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.66857913 |
14 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.65144208 |
15 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.56269614 |
16 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.54928980 |
17 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.52280975 |
18 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.51193587 |
19 | * CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.47140963 |
20 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.43468596 |
21 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.29638742 |
22 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.19188543 |
23 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.18434105 |
24 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.09952701 |
25 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.08571051 |
26 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.05485416 |
27 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.01043093 |
28 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.87304566 |
29 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.86884453 |
30 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.86160084 |
31 | * THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.86040463 |
32 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.82143763 |
33 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.75969660 |
34 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.72434859 |
35 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.64070736 |
36 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.62613374 |
37 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.61508159 |
38 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.61197433 |
39 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.59520311 |
40 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.58843173 |
41 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.56129681 |
42 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.54687870 |
43 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.52315496 |
44 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.51958931 |
45 | MYB_26560356_Chip-Seq_TH2_Human | 1.50763415 |
46 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.50596840 |
47 | GATA1_22025678_ChIP-Seq_K562_Human | 1.50382978 |
48 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.49697647 |
49 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.49216007 |
50 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.47854840 |
51 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.46386139 |
52 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.46119925 |
53 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45877621 |
54 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.45706442 |
55 | MAF_26560356_Chip-Seq_TH1_Human | 1.43213768 |
56 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.42056558 |
57 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.41322106 |
58 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.40781076 |
59 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.39703662 |
60 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.39118300 |
61 | CJUN_26792858_Chip-Seq_BT549_Human | 1.38769038 |
62 | * CDX2_22108803_ChIP-Seq_LS180_Human | 1.36480751 |
63 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.36302465 |
64 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35973543 |
65 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.35293272 |
66 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.35243092 |
67 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.34835183 |
68 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.33491006 |
69 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.32820875 |
70 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.32580316 |
71 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.32251880 |
72 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.31421037 |
73 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.31121808 |
74 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.31121808 |
75 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.30818976 |
76 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.29615737 |
77 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.28074833 |
78 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.27744443 |
79 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.27257465 |
80 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.27096920 |
81 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.27031435 |
82 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.23904307 |
83 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.22189534 |
84 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.21879207 |
85 | MYB_26560356_Chip-Seq_TH1_Human | 1.20901525 |
86 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.19356692 |
87 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.18565013 |
88 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.18520108 |
89 | SPI1_23127762_ChIP-Seq_K562_Human | 1.18288187 |
90 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.17211950 |
91 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.16415505 |
92 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.15654080 |
93 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.15432982 |
94 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.15209369 |
95 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.14628694 |
96 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.14608550 |
97 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14455705 |
98 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.14359885 |
99 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.14163259 |
100 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.13837447 |
101 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.12049899 |
102 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.11638496 |
103 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.10987396 |
104 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.10887188 |
105 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.10427178 |
106 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10332051 |
107 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.10276963 |
108 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.10251529 |
109 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.07398238 |
110 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07091977 |
111 | GATA2_19941826_ChIP-Seq_K562_Human | 1.06691708 |
112 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.05524267 |
113 | GATA1_19941826_ChIP-Seq_K562_Human | 1.03931543 |
114 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03347485 |
115 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03305218 |
116 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.99764301 |
117 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.98291715 |
118 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.96545847 |
119 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.95227452 |
120 | UTX_26944678_Chip-Seq_JUKART_Human | 0.94742786 |
121 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.93994367 |
122 | GATA3_26560356_Chip-Seq_TH2_Human | 0.93993295 |
123 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.92613623 |
124 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.91394875 |
125 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.90194864 |
126 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.89803045 |
127 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.89653692 |
128 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.89493210 |
129 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.89044912 |
130 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.89004446 |
131 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.88217692 |
132 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.86952886 |
133 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.86832191 |
134 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.85928528 |
135 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.85696814 |
136 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.84209129 |
137 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.84082324 |
138 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.83950956 |
139 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.83710745 |
140 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.83706730 |
141 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.82956949 |
142 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.81667217 |
143 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.81626797 |
144 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.81524913 |
145 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.81484516 |
146 | CBP_21632823_ChIP-Seq_H3396_Human | 0.81405960 |
147 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.80952178 |
148 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.80902613 |
149 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.80743621 |
150 | TP53_16413492_ChIP-PET_HCT116_Human | 0.79461533 |
151 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.78484330 |
152 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.78419991 |
153 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.78066282 |
154 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.77945840 |
155 | * TCF4_22108803_ChIP-Seq_LS180_Human | 0.77521132 |
156 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.77024724 |
157 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.76971366 |
158 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.76570858 |
159 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.74716162 |
160 | RXR_22108803_ChIP-Seq_LS180_Human | 0.73884654 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005360_urolithiasis | 3.23509971 |
2 | MP0005058_abnormal_lysosome_morphology | 3.16962569 |
3 | MP0010234_abnormal_vibrissa_follicle | 3.14955298 |
4 | MP0002138_abnormal_hepatobiliary_system | 2.88234662 |
5 | MP0001835_abnormal_antigen_presentation | 2.84827259 |
6 | MP0003724_increased_susceptibility_to | 2.75042450 |
7 | MP0009840_abnormal_foam_cell | 2.65236916 |
8 | MP0003436_decreased_susceptibility_to | 2.59085078 |
9 | MP0002139_abnormal_hepatobiliary_system | 2.43369242 |
10 | MP0000685_abnormal_immune_system | 2.34807178 |
11 | MP0009785_altered_susceptibility_to | 2.30532640 |
12 | MP0002419_abnormal_innate_immunity | 2.16839499 |
13 | MP0005332_abnormal_amino_acid | 2.15847940 |
14 | MP0003191_abnormal_cellular_cholesterol | 2.15517253 |
15 | MP0005365_abnormal_bile_salt | 2.13336950 |
16 | MP0002876_abnormal_thyroid_physiology | 2.11186331 |
17 | MP0003868_abnormal_feces_composition | 2.09797098 |
18 | MP0002148_abnormal_hypersensitivity_rea | 2.07184776 |
19 | MP0006082_CNS_inflammation | 2.05243034 |
20 | MP0005025_abnormal_response_to | 2.04847968 |
21 | MP0005387_immune_system_phenotype | 1.98701482 |
22 | MP0001790_abnormal_immune_system | 1.98701482 |
23 | MP0004019_abnormal_vitamin_homeostasis | 1.96985458 |
24 | MP0008875_abnormal_xenobiotic_pharmacok | 1.96198761 |
25 | MP0009643_abnormal_urine_homeostasis | 1.94040090 |
26 | MP0005000_abnormal_immune_tolerance | 1.91834412 |
27 | MP0005671_abnormal_response_to | 1.80698514 |
28 | MP0003300_gastrointestinal_ulcer | 1.79812424 |
29 | MP0003186_abnormal_redox_activity | 1.76706019 |
30 | MP0002254_reproductive_system_inflammat | 1.74990542 |
31 | MP0001853_heart_inflammation | 1.74857802 |
32 | MP0009780_abnormal_chondrocyte_physiolo | 1.71266209 |
33 | MP0005464_abnormal_platelet_physiology | 1.70814238 |
34 | MP0002452_abnormal_antigen_presenting | 1.67621488 |
35 | MP0009764_decreased_sensitivity_to | 1.65095771 |
36 | MP0001666_abnormal_nutrient_absorption | 1.63471069 |
37 | MP0005085_abnormal_gallbladder_physiolo | 1.62753621 |
38 | MP0000343_altered_response_to | 1.60861930 |
39 | MP0001845_abnormal_inflammatory_respons | 1.60483725 |
40 | MP0008469_abnormal_protein_level | 1.59577310 |
41 | MP0003075_altered_response_to | 1.59332623 |
42 | MP0002723_abnormal_immune_serum | 1.56058850 |
43 | MP0001533_abnormal_skeleton_physiology | 1.55737022 |
44 | MP0001800_abnormal_humoral_immune | 1.53455960 |
45 | MP0001873_stomach_inflammation | 1.52331841 |
46 | MP0003303_peritoneal_inflammation | 1.51521995 |
47 | MP0002136_abnormal_kidney_physiology | 1.50557858 |
48 | MP0001819_abnormal_immune_cell | 1.49894172 |
49 | MP0002420_abnormal_adaptive_immunity | 1.49323038 |
50 | MP0010155_abnormal_intestine_physiology | 1.46169553 |
51 | MP0004147_increased_porphyrin_level | 1.44844860 |
52 | MP0003172_abnormal_lysosome_physiology | 1.42129699 |
53 | MP0005083_abnormal_biliary_tract | 1.41733215 |
54 | MP0010329_abnormal_lipoprotein_level | 1.37829642 |
55 | MP0005319_abnormal_enzyme/_coenzyme | 1.36580183 |
56 | MP0002166_altered_tumor_susceptibility | 1.35637699 |
57 | MP0003879_abnormal_hair_cell | 1.35631893 |
58 | MP0004947_skin_inflammation | 1.35453278 |
59 | MP0004264_abnormal_extraembryonic_tissu | 1.35301012 |
60 | MP0003195_calcinosis | 1.35149944 |
61 | MP0002405_respiratory_system_inflammati | 1.32206847 |
62 | MP0010352_gastrointestinal_tract_polyps | 1.32038584 |
63 | MP0000604_amyloidosis | 1.27888084 |
64 | MP0004510_myositis | 1.27760159 |
65 | MP0002796_impaired_skin_barrier | 1.25691228 |
66 | MP0005636_abnormal_mineral_homeostasis | 1.25608302 |
67 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.23902429 |
68 | MP0005167_abnormal_blood-brain_barrier | 1.23305793 |
69 | MP0001958_emphysema | 1.22358542 |
70 | MP0001756_abnormal_urination | 1.20992349 |
71 | MP0002909_abnormal_adrenal_gland | 1.19475044 |
72 | MP0003252_abnormal_bile_duct | 1.19203524 |
73 | MP0005166_decreased_susceptibility_to | 1.18243895 |
74 | MP0000465_gastrointestinal_hemorrhage | 1.17843004 |
75 | MP0002998_abnormal_bone_remodeling | 1.17180202 |
76 | MP0004043_abnormal_pH_regulation | 1.17081614 |
77 | MP0001765_abnormal_ion_homeostasis | 1.15821156 |
78 | MP0000609_abnormal_liver_physiology | 1.14982315 |
79 | MP0004782_abnormal_surfactant_physiolog | 1.13035020 |
80 | MP0002971_abnormal_brown_adipose | 1.12683326 |
81 | MP0005275_abnormal_skin_tensile | 1.11778487 |
82 | MP0003329_amyloid_beta_deposits | 1.11734041 |
83 | MP0003690_abnormal_glial_cell | 1.09986530 |
84 | MP0000716_abnormal_immune_system | 1.07140139 |
85 | MP0002118_abnormal_lipid_homeostasis | 1.05942222 |
86 | MP0008438_abnormal_cutaneous_collagen | 1.02855357 |
87 | MP0005377_hearing/vestibular/ear_phenot | 1.01406216 |
88 | MP0003878_abnormal_ear_physiology | 1.01406216 |
89 | MP0001664_abnormal_digestion | 1.01174491 |
90 | MP0010678_abnormal_skin_adnexa | 1.01160789 |
91 | MP0010386_abnormal_urinary_bladder | 1.00047542 |
92 | MP0003763_abnormal_thymus_physiology | 0.99505237 |
93 | MP0000689_abnormal_spleen_morphology | 0.99013238 |
94 | MP0003806_abnormal_nucleotide_metabolis | 0.98386648 |
95 | MP0005310_abnormal_salivary_gland | 0.97595935 |
96 | MP0005165_increased_susceptibility_to | 0.96667115 |
97 | MP0000538_abnormal_urinary_bladder | 0.96222892 |
98 | MP0003183_abnormal_peptide_metabolism | 0.96215968 |
99 | MP0002006_tumorigenesis | 0.95521892 |
100 | MP0005535_abnormal_body_temperature | 0.94427312 |
101 | MP0003638_abnormal_response/metabolism_ | 0.94388550 |
102 | MP0009333_abnormal_splenocyte_physiolog | 0.93900069 |
103 | MP0005448_abnormal_energy_balance | 0.93864833 |
104 | MP0004130_abnormal_muscle_cell | 0.93714310 |
105 | MP0003866_abnormal_defecation | 0.93427123 |
106 | MP0001663_abnormal_digestive_system | 0.93259905 |
107 | MP0001764_abnormal_homeostasis | 0.92330497 |
108 | MP0003656_abnormal_erythrocyte_physiolo | 0.91986915 |
109 | MP0005257_abnormal_intraocular_pressure | 0.90648793 |
110 | MP0005409_darkened_coat_color | 0.90437547 |
111 | MP0006054_spinal_hemorrhage | 0.90348221 |
112 | MP0002933_joint_inflammation | 0.89176252 |
113 | MP0002722_abnormal_immune_system | 0.88993846 |
114 | MP0002398_abnormal_bone_marrow | 0.88521327 |
115 | MP0002078_abnormal_glucose_homeostasis | 0.88361902 |
116 | MP0009763_increased_sensitivity_to | 0.88074995 |
117 | MP0002896_abnormal_bone_mineralization | 0.87339692 |
118 | MP0005670_abnormal_white_adipose | 0.86504018 |
119 | MP0002429_abnormal_blood_cell | 0.85893439 |
120 | MP0002132_abnormal_respiratory_system | 0.85735014 |
121 | MP0001501_abnormal_sleep_pattern | 0.85593797 |
122 | MP0003828_pulmonary_edema | 0.84065612 |
123 | MP0005451_abnormal_body_composition | 0.83855688 |
124 | MP0000858_altered_metastatic_potential | 0.80721755 |
125 | MP0005084_abnormal_gallbladder_morpholo | 0.80496705 |
126 | MP0005164_abnormal_response_to | 0.77744419 |
127 | MP0008004_abnormal_stomach_pH | 0.77523287 |
128 | MP0009642_abnormal_blood_homeostasis | 0.73936769 |
129 | MP0000230_abnormal_systemic_arterial | 0.71180443 |
130 | MP0002098_abnormal_vibrissa_morphology | 0.67745714 |
131 | MP0005376_homeostasis/metabolism_phenot | 0.66708539 |
132 | MP0002693_abnormal_pancreas_physiology | 0.63673294 |
133 | MP0003453_abnormal_keratinocyte_physiol | 0.62718874 |
134 | MP0000462_abnormal_digestive_system | 0.61940225 |
135 | MP0005381_digestive/alimentary_phenotyp | 0.60158963 |
136 | MP0001542_abnormal_bone_strength | 0.59478593 |
137 | MP0004270_analgesia | 0.59138024 |
138 | MP0009115_abnormal_fat_cell | 0.57653631 |
139 | MP0003953_abnormal_hormone_level | 0.57154973 |
140 | MP0004272_abnormal_basement_membrane | 0.56838137 |
141 | MP0000013_abnormal_adipose_tissue | 0.56489312 |
142 | MP0000477_abnormal_intestine_morphology | 0.56465676 |
143 | MP0005408_hypopigmentation | 0.56301104 |
144 | MP0002837_dystrophic_cardiac_calcinosis | 0.56078370 |
145 | MP0009379_abnormal_foot_pigmentation | 0.54887251 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Vacuolated lymphocytes (HP:0001922) | 4.91965731 |
2 | Hypobetalipoproteinemia (HP:0003563) | 4.84863012 |
3 | Malnutrition (HP:0004395) | 4.61491178 |
4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.53704547 |
5 | Eczematoid dermatitis (HP:0000976) | 4.26346748 |
6 | Fat malabsorption (HP:0002630) | 4.09043399 |
7 | Recurrent abscess formation (HP:0002722) | 4.08709552 |
8 | Abnormality of macrophages (HP:0004311) | 3.90588991 |
9 | Systemic lupus erythematosus (HP:0002725) | 3.80589198 |
10 | Dysostosis multiplex (HP:0000943) | 3.76917475 |
11 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.73586602 |
12 | Recurrent bacterial skin infections (HP:0005406) | 3.69679891 |
13 | Conjugated hyperbilirubinemia (HP:0002908) | 3.56033685 |
14 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.41363298 |
15 | Mucopolysacchariduria (HP:0008155) | 3.41363298 |
16 | Prolonged partial thromboplastin time (HP:0003645) | 3.32974511 |
17 | Steatorrhea (HP:0002570) | 3.25587841 |
18 | Abnormality of complement system (HP:0005339) | 3.22095106 |
19 | Intrahepatic cholestasis (HP:0001406) | 3.18351159 |
20 | Hyperactive renin-angiotensin system (HP:0000841) | 3.16155346 |
21 | Generalized aminoaciduria (HP:0002909) | 3.15605667 |
22 | Hypolipoproteinemia (HP:0010981) | 3.15379769 |
23 | Gout (HP:0001997) | 3.12754951 |
24 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.12326066 |
25 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.12326066 |
26 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.12326066 |
27 | Abnormality of vitamin metabolism (HP:0100508) | 3.11653203 |
28 | Myositis (HP:0100614) | 3.10883517 |
29 | Increased cerebral lipofuscin (HP:0011813) | 3.09898219 |
30 | Hyperglycinuria (HP:0003108) | 3.06444272 |
31 | Hypokalemic alkalosis (HP:0001949) | 3.02589510 |
32 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.95261091 |
33 | Deep venous thrombosis (HP:0002625) | 2.90086806 |
34 | Abnormality of vitamin B metabolism (HP:0004340) | 2.87127684 |
35 | Abnormality of purine metabolism (HP:0004352) | 2.83404946 |
36 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.78414144 |
37 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.78388507 |
38 | Axonal loss (HP:0003447) | 2.77679012 |
39 | Metabolic alkalosis (HP:0200114) | 2.76511011 |
40 | Widely patent fontanelles and sutures (HP:0004492) | 2.76393411 |
41 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.69662180 |
42 | Pustule (HP:0200039) | 2.68498116 |
43 | Proximal tubulopathy (HP:0000114) | 2.66508110 |
44 | Orchitis (HP:0100796) | 2.64370668 |
45 | Abnormality of chloride homeostasis (HP:0011422) | 2.64170489 |
46 | Autoimmune thrombocytopenia (HP:0001973) | 2.60363596 |
47 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.51989646 |
48 | Skin nodule (HP:0200036) | 2.51346515 |
49 | Xanthomatosis (HP:0000991) | 2.50898622 |
50 | IgM deficiency (HP:0002850) | 2.49309535 |
51 | Interstitial pulmonary disease (HP:0006530) | 2.49127240 |
52 | Congenital sensorineural hearing impairment (HP:0008527) | 2.48952743 |
53 | Abnormality of glycine metabolism (HP:0010895) | 2.48619676 |
54 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.48619676 |
55 | Epidermoid cyst (HP:0200040) | 2.47955943 |
56 | Hydroxyprolinuria (HP:0003080) | 2.47246219 |
57 | Abnormality of proline metabolism (HP:0010907) | 2.47246219 |
58 | Recurrent skin infections (HP:0001581) | 2.45080867 |
59 | Spontaneous hematomas (HP:0007420) | 2.43139547 |
60 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.43097926 |
61 | Abnormality of renal excretion (HP:0011036) | 2.40525772 |
62 | Increased circulating renin level (HP:0000848) | 2.39099404 |
63 | Glomerulonephritis (HP:0000099) | 2.38378978 |
64 | Hyperglycemia (HP:0003074) | 2.38247468 |
65 | Hypoglycemic coma (HP:0001325) | 2.35134464 |
66 | Increased CSF protein (HP:0002922) | 2.34380085 |
67 | Gingivitis (HP:0000230) | 2.33437768 |
68 | Abnormality of the nasal mucosa (HP:0000433) | 2.33412459 |
69 | Abnormal urine output (HP:0012590) | 2.33317764 |
70 | Esophageal varix (HP:0002040) | 2.31743046 |
71 | Polyuria (HP:0000103) | 2.30935684 |
72 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.29433833 |
73 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.29433833 |
74 | Abnormality of glycolipid metabolism (HP:0010969) | 2.29433833 |
75 | Loss of speech (HP:0002371) | 2.26467927 |
76 | Ketoacidosis (HP:0001993) | 2.26262817 |
77 | Hyperlipoproteinemia (HP:0010980) | 2.26093189 |
78 | Hyperammonemia (HP:0001987) | 2.26082939 |
79 | Chronic diarrhea (HP:0002028) | 2.26006527 |
80 | Petechiae (HP:0000967) | 2.25528478 |
81 | Hypomagnesemia (HP:0002917) | 2.24457406 |
82 | Decreased circulating renin level (HP:0003351) | 2.23843666 |
83 | Protuberant abdomen (HP:0001538) | 2.23292002 |
84 | Abdominal distention (HP:0003270) | 2.23006107 |
85 | Hyperuricemia (HP:0002149) | 2.22425843 |
86 | Increased purine levels (HP:0004368) | 2.22425843 |
87 | Mitral stenosis (HP:0001718) | 2.21335347 |
88 | Ketosis (HP:0001946) | 2.21047107 |
89 | Hypothermia (HP:0002045) | 2.20540693 |
90 | Recurrent fungal infections (HP:0002841) | 2.19830142 |
91 | Amyloidosis (HP:0011034) | 2.19131271 |
92 | Urticaria (HP:0001025) | 2.18915945 |
93 | Abnormality of nucleobase metabolism (HP:0010932) | 2.18423042 |
94 | Alkalosis (HP:0001948) | 2.18308563 |
95 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.17517614 |
96 | Joint hemorrhage (HP:0005261) | 2.16779159 |
97 | Symptomatic seizures (HP:0011145) | 2.15798941 |
98 | Vascular calcification (HP:0004934) | 2.14111771 |
99 | Renal tubular acidosis (HP:0001947) | 2.13199275 |
100 | Chronic obstructive pulmonary disease (HP:0006510) | 2.11781003 |
101 | Obstructive lung disease (HP:0006536) | 2.11781003 |
102 | Asymmetric septal hypertrophy (HP:0001670) | 2.10967770 |
103 | Mediastinal lymphadenopathy (HP:0100721) | 2.10920125 |
104 | Hematochezia (HP:0002573) | 2.10004504 |
105 | Nausea (HP:0002018) | 2.09786356 |
106 | Abnormality of magnesium homeostasis (HP:0004921) | 2.09633853 |
107 | Right ventricular cardiomyopathy (HP:0011663) | 2.08175124 |
108 | Optic neuritis (HP:0100653) | 2.07680985 |
109 | Retrobulbar optic neuritis (HP:0100654) | 2.07680985 |
110 | Tetany (HP:0001281) | 2.06880527 |
111 | Rickets (HP:0002748) | 2.06179641 |
112 | Nasal polyposis (HP:0100582) | 2.03483978 |
113 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.03261026 |
114 | Dicarboxylic aciduria (HP:0003215) | 2.03261026 |
115 | Hypophosphatemia (HP:0002148) | 2.01989798 |
116 | Myocardial infarction (HP:0001658) | 2.01968584 |
117 | Complement deficiency (HP:0004431) | 1.99677503 |
118 | Thoracic kyphosis (HP:0002942) | 1.99236087 |
119 | Beaking of vertebral bodies (HP:0004568) | 1.98056449 |
120 | Glycosuria (HP:0003076) | 1.97826463 |
121 | Abnormality of urine glucose concentration (HP:0011016) | 1.97826463 |
122 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.96840529 |
123 | Late onset (HP:0003584) | 1.95584997 |
124 | Abnormality of the lumbar spine (HP:0100712) | 1.95408938 |
125 | Hyperphosphaturia (HP:0003109) | 1.94116516 |
126 | Hyperaldosteronism (HP:0000859) | 1.93583500 |
127 | Irritability (HP:0000737) | 1.92580020 |
128 | Metaphyseal irregularity (HP:0003025) | 1.91941849 |
129 | Nephritis (HP:0000123) | 1.90506357 |
130 | Pancreatitis (HP:0001733) | 1.89210944 |
131 | Abnormality of the common coagulation pathway (HP:0010990) | 1.88673462 |
132 | Abnormality of renin-angiotensin system (HP:0000847) | 1.88503991 |
133 | Anorexia (HP:0002039) | 1.88165105 |
134 | Hypoglycemic seizures (HP:0002173) | 1.87960717 |
135 | Exocrine pancreatic insufficiency (HP:0001738) | 1.87791230 |
136 | Renal salt wasting (HP:0000127) | 1.87714958 |
137 | Arterial thrombosis (HP:0004420) | 1.86367679 |
138 | Cardiovascular calcification (HP:0011915) | 1.85689626 |
139 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.85255318 |
140 | Tetraparesis (HP:0002273) | 1.85040805 |
141 | Hypoalphalipoproteinemia (HP:0003233) | 1.84003596 |
142 | Acanthocytosis (HP:0001927) | 1.83806750 |
143 | Progressive neurologic deterioration (HP:0002344) | 1.83435250 |
144 | Epistaxis (HP:0000421) | 1.82831009 |
145 | Hypokalemia (HP:0002900) | 1.81071511 |
146 | Hypotension (HP:0002615) | 1.79866745 |
147 | Thin bony cortex (HP:0002753) | 1.79023899 |
148 | Hyperparathyroidism (HP:0000843) | 1.75661625 |
149 | Hypercholesterolemia (HP:0003124) | 1.74688692 |
150 | Prolonged neonatal jaundice (HP:0006579) | 1.74032437 |
151 | Nephrolithiasis (HP:0000787) | 1.73974495 |
152 | Metabolic acidosis (HP:0001942) | 1.73157096 |
153 | Osteomalacia (HP:0002749) | 1.72607064 |
154 | Abnormal urine phosphate concentration (HP:0012599) | 1.72383374 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ACVR1B | 4.92654796 |
2 | ERN1 | 3.23627833 |
3 | FRK | 3.10590205 |
4 | BCKDK | 3.10036624 |
5 | MAP4K1 | 2.82968200 |
6 | TGFBR2 | 2.46644321 |
7 | TBK1 | 2.41014389 |
8 | STK39 | 2.38974089 |
9 | IRAK3 | 2.31782709 |
10 | TYK2 | 2.26967770 |
11 | MAP3K14 | 2.24871059 |
12 | MAP3K3 | 2.23998864 |
13 | MST1R | 2.23031793 |
14 | BLK | 2.22700519 |
15 | IRAK4 | 2.18174137 |
16 | ZAP70 | 2.08916374 |
17 | KIT | 2.06592853 |
18 | DDR2 | 2.06476918 |
19 | TXK | 2.03365853 |
20 | MAP2K3 | 2.02236402 |
21 | IKBKE | 1.96024320 |
22 | KDR | 1.93615378 |
23 | TRIB3 | 1.92311019 |
24 | NME2 | 1.92060091 |
25 | MST4 | 1.72302095 |
26 | AKT3 | 1.65975817 |
27 | TIE1 | 1.65938918 |
28 | JAK3 | 1.65910663 |
29 | PHKG1 | 1.64470671 |
30 | PHKG2 | 1.64470671 |
31 | EPHB1 | 1.63994382 |
32 | WNK4 | 1.63298276 |
33 | BTK | 1.62058973 |
34 | EPHA2 | 1.59275128 |
35 | FGFR4 | 1.55811426 |
36 | GRK1 | 1.55566101 |
37 | LRRK2 | 1.54491248 |
38 | ADRBK2 | 1.51075378 |
39 | FER | 1.49499976 |
40 | STK10 | 1.48068090 |
41 | ERBB3 | 1.45147650 |
42 | TEC | 1.44700900 |
43 | PIM2 | 1.44404526 |
44 | RIPK4 | 1.40502211 |
45 | IKBKB | 1.35940022 |
46 | JAK1 | 1.34758145 |
47 | RIPK1 | 1.30773193 |
48 | GRK6 | 1.29934936 |
49 | TAOK3 | 1.25075319 |
50 | WNK3 | 1.19495201 |
51 | OBSCN | 1.13919755 |
52 | STK38L | 1.12402193 |
53 | MAP4K2 | 1.10361419 |
54 | CSK | 1.08400282 |
55 | CSF1R | 1.05237965 |
56 | STK24 | 1.04819400 |
57 | TESK1 | 1.01649308 |
58 | SYK | 1.01206072 |
59 | NLK | 0.99376465 |
60 | DAPK2 | 0.97774347 |
61 | OXSR1 | 0.97383532 |
62 | TRPM7 | 0.94828012 |
63 | NEK9 | 0.94447400 |
64 | JAK2 | 0.93996568 |
65 | TAOK1 | 0.93631900 |
66 | ABL2 | 0.92995123 |
67 | MYLK | 0.92931866 |
68 | LMTK2 | 0.92232260 |
69 | SIK1 | 0.91809272 |
70 | MAP3K13 | 0.91108561 |
71 | HCK | 0.90729222 |
72 | MATK | 0.89091551 |
73 | ITK | 0.88239098 |
74 | FGFR2 | 0.87219941 |
75 | LCK | 0.84975263 |
76 | LYN | 0.84959961 |
77 | CAMK2D | 0.84869356 |
78 | MAP3K11 | 0.83551236 |
79 | PKN2 | 0.78348871 |
80 | PRKG2 | 0.78243810 |
81 | CDC42BPA | 0.77624983 |
82 | PDPK1 | 0.75729998 |
83 | PDK2 | 0.74986334 |
84 | PIK3CG | 0.73301786 |
85 | PRKCE | 0.72532620 |
86 | PTK6 | 0.70912065 |
87 | FGFR3 | 0.69786966 |
88 | TNIK | 0.69654437 |
89 | MAP3K12 | 0.69379740 |
90 | LIMK1 | 0.69200897 |
91 | EPHA3 | 0.68960138 |
92 | BMPR2 | 0.68924605 |
93 | IRAK1 | 0.68398927 |
94 | MAP2K2 | 0.67523666 |
95 | MARK3 | 0.66438082 |
96 | DYRK1B | 0.66273402 |
97 | TRIM28 | 0.65598508 |
98 | PIM1 | 0.63737456 |
99 | RPS6KA4 | 0.63566723 |
100 | EPHB2 | 0.61747228 |
101 | STK3 | 0.61697802 |
102 | FES | 0.61287331 |
103 | MUSK | 0.60926694 |
104 | MAPKAPK3 | 0.59603049 |
105 | TGFBR1 | 0.59079631 |
106 | PINK1 | 0.57337988 |
107 | EIF2AK3 | 0.56307848 |
108 | PRKACG | 0.56051658 |
109 | CAMK1D | 0.55508480 |
110 | TTN | 0.55126881 |
111 | CHUK | 0.54973283 |
112 | MAPK7 | 0.54761177 |
113 | MAP2K6 | 0.53850726 |
114 | MAPK11 | 0.53423693 |
115 | YES1 | 0.53140131 |
116 | ARAF | 0.52547886 |
117 | NTRK3 | 0.52360895 |
118 | CAMKK2 | 0.52155464 |
119 | PAK3 | 0.51755441 |
120 | MAPK12 | 0.51334495 |
121 | CAMK2G | 0.51165563 |
122 | PRKCD | 0.50039023 |
123 | MAP3K5 | 0.49877788 |
124 | MAP3K6 | 0.49338755 |
125 | PDGFRA | 0.48949212 |
126 | GSK3A | 0.47161899 |
127 | MET | 0.47056216 |
128 | CASK | 0.45880964 |
129 | MAPK4 | 0.45801006 |
130 | MAP3K1 | 0.45262378 |
131 | PDK3 | 0.45239722 |
132 | PDK4 | 0.45239722 |
133 | ABL1 | 0.45112689 |
134 | IGF1R | 0.45103361 |
135 | GRK7 | 0.44995329 |
136 | MAP3K2 | 0.44613298 |
137 | PDK1 | 0.44509861 |
138 | PRKCA | 0.43373590 |
139 | MAP3K7 | 0.43333965 |
140 | PAK4 | 0.43300231 |
141 | PRKAA2 | 0.42443862 |
142 | PRKCZ | 0.41879067 |
143 | PTK2 | 0.40855013 |
144 | PRKAA1 | 0.39080325 |
145 | BMPR1B | 0.37640963 |
146 | SGK3 | 0.37113406 |
147 | ADRBK1 | 0.36910460 |
148 | PIK3CA | 0.36240822 |
149 | PRKCQ | 0.35195435 |
150 | EGFR | 0.35070948 |
151 | STK38 | 0.34356644 |
152 | FGR | 0.33768743 |
153 | PRKG1 | 0.32674029 |
154 | MAP2K4 | 0.31006982 |
155 | MAP3K4 | 0.30402619 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Other glycan degradation_Homo sapiens_hsa00511 | 2.85108815 |
2 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.82188880 |
3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.69284437 |
4 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.56260370 |
5 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.43379753 |
6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.42456216 |
7 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.34173953 |
8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.28195513 |
9 | Lysosome_Homo sapiens_hsa04142 | 2.16268234 |
10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.02744482 |
11 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.89900537 |
12 | Peroxisome_Homo sapiens_hsa04146 | 1.89682470 |
13 | Leishmaniasis_Homo sapiens_hsa05140 | 1.83503196 |
14 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.73687201 |
15 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.58786363 |
16 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.56190244 |
17 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.54168451 |
18 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.53469649 |
19 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.51094393 |
20 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.49667929 |
21 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.49264519 |
22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.47260044 |
23 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.45087577 |
24 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.38214603 |
25 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.37522162 |
26 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.35655656 |
27 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.34054523 |
28 | Histidine metabolism_Homo sapiens_hsa00340 | 1.33247417 |
29 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.32683644 |
30 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.31577127 |
31 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.27486981 |
32 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.27411851 |
33 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.24480674 |
34 | Pertussis_Homo sapiens_hsa05133 | 1.20871334 |
35 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.20658331 |
36 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.18949451 |
37 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.15764415 |
38 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.13936999 |
39 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.13845678 |
40 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.13555128 |
41 | Tuberculosis_Homo sapiens_hsa05152 | 1.13524197 |
42 | Legionellosis_Homo sapiens_hsa05134 | 1.10966357 |
43 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.10246732 |
44 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.10095552 |
45 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.09486216 |
46 | Malaria_Homo sapiens_hsa05144 | 1.09453207 |
47 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.09400114 |
48 | Galactose metabolism_Homo sapiens_hsa00052 | 1.05655287 |
49 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.05331377 |
50 | Mineral absorption_Homo sapiens_hsa04978 | 1.05324029 |
51 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.05016697 |
52 | Sulfur relay system_Homo sapiens_hsa04122 | 1.04870964 |
53 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.98865833 |
54 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.98373598 |
55 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.98268058 |
56 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.98171335 |
57 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.98118065 |
58 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.96430575 |
59 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.95767287 |
60 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.94947306 |
61 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.94172216 |
62 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.93806038 |
63 | Bile secretion_Homo sapiens_hsa04976 | 0.93004993 |
64 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.92633452 |
65 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.91514695 |
66 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.90432829 |
67 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.89948374 |
68 | Carbon metabolism_Homo sapiens_hsa01200 | 0.89103712 |
69 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.87571201 |
70 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.87182600 |
71 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.84191026 |
72 | Measles_Homo sapiens_hsa05162 | 0.83932901 |
73 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.82618305 |
74 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.81597933 |
75 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.79345475 |
76 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.78909409 |
77 | Phagosome_Homo sapiens_hsa04145 | 0.78088264 |
78 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.77113347 |
79 | ABC transporters_Homo sapiens_hsa02010 | 0.76655257 |
80 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.74450507 |
81 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.74217587 |
82 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.74154779 |
83 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.74095226 |
84 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.73979870 |
85 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.72894175 |
86 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.72800586 |
87 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.72443991 |
88 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.70640699 |
89 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.67621731 |
90 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.66717965 |
91 | Retinol metabolism_Homo sapiens_hsa00830 | 0.65693263 |
92 | Salmonella infection_Homo sapiens_hsa05132 | 0.64518458 |
93 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.63263865 |
94 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.62978443 |
95 | Shigellosis_Homo sapiens_hsa05131 | 0.62273984 |
96 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.62263466 |
97 | Influenza A_Homo sapiens_hsa05164 | 0.61792187 |
98 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.58904817 |
99 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.57568161 |
100 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.57541135 |
101 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.57279418 |
102 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.57179583 |
103 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.57009309 |
104 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.56493769 |
105 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.54995025 |
106 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.54942429 |
107 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.53951652 |
108 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.53729462 |
109 | Hepatitis C_Homo sapiens_hsa05160 | 0.53285445 |
110 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.51841311 |
111 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.50906665 |
112 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.48757359 |
113 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.48250718 |
114 | Insulin resistance_Homo sapiens_hsa04931 | 0.44743749 |
115 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.38629007 |
116 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.37822860 |
117 | Metabolic pathways_Homo sapiens_hsa01100 | 0.36979920 |
118 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.35407491 |
119 | Insulin secretion_Homo sapiens_hsa04911 | 0.32775598 |
120 | Circadian rhythm_Homo sapiens_hsa04710 | 0.32114746 |
121 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.29875407 |
122 | Renin secretion_Homo sapiens_hsa04924 | 0.29158556 |
123 | Prion diseases_Homo sapiens_hsa05020 | 0.25862518 |
124 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.24318007 |
125 | Amoebiasis_Homo sapiens_hsa05146 | 0.23205039 |
126 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.22105510 |
127 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.21607472 |
128 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.19513759 |
129 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.19483108 |